SIBN

SI-BONE Inc.

Price

$19.91

return (12m)

28.53%

p/e

-57.02

p/bv

4.57

DIVIDEND YIELD

0.00%

SIBN price

SI-BONE

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment SIBN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

15.92%

3 months

34.44%

1 year

28.53%

2 years

39.04%

5 years

-2.78%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals SIBN

Valuation

P/E

-57.02

Sector -2.19

Industry 1.21

P/BV

4.57

Sector 2.22

Industry 2.11

P/Revenue (PSR)

3.91

Sector 2.01

Industry 0.78

EV/EBITDA

-399.96

Sector -17.81

Industry -25.30

EV/EBIT

-207.43

Sector -26.72

Industry -18.04

P/EBITDA

-145.59

Sector 0.36

Industry 0.18

P/EBIT

-68.72

Sector -3.34

Industry 1.26

P/Total Assets

3.35

Sector 1.23

Industry 0.86

P/Net Current Assets

5.43

Sector -27.35

Industry -12.37

P/Working Capital

4.26

Sector -4.54

Industry -49.48

EPS

-0.33

Sector -0.87

Industry -0.55

BVPS

4.14

Sector 3.80

Industry 5.36

Efficiency

Gross Margin

79.52%

Sector 43.36%

Industry 31.53%

EBITDA Margin

-3.23%

Sector -323.65%

Industry -73.39%

EBIT Margin

-6.23%

Sector -194.57%

Industry -11.94%

Operating Margin

-8.30%

Sector -24.37%

Industry -9.87%

Net Profit Margins

-6.85%

Sector -28.88%

Industry -19.76%

Asset Turnover

0.23

Sector 0.12

Industry 0.22

Profitability

ROE

-8.02%

Sector -33.82%

Industry -37.56%

ROA

-5.88%

Sector -29.63%

Industry -17.56%

ROIC

-21.85%

Sector -431.16%

Industry -111.59%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

9.15

Sector 1.84

Industry 1.14

Net Debt / EBITDA

60.94

Sector -1.47

Industry -31.86

Net Debt / EBIT

31.61

Sector -1.32

Industry 2.06

Net Debt / Equity

-0.60

Sector -0.35

Industry 0.14

Gross Debt / Equity

0.20

Sector 0.14

Industry 0.51

Equity/Assets

0.73

Sector 0.42

Industry 0.25

Liabilities/Assets

0.27

Sector 0.46

Industry 0.46

Growth

5Y Revenue CAGR

18.83%

Sector -

Industry -

5Y Earnings CAGR

-23.70%

Sector -

Industry -

Fundamentals SIBN

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
SIBN SI-BONE Inc.	$19.91	28.12%	0.00%	-57.02	4.57	-8.02%	-6.85%
ISRG Intuitive Surgical Inc.	$397.72	-17.36%	0.00%	45.09	7.73	17.15%	28.45%
ABT Abbott Laboratories	$114.43	-11.62%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$94.13	4.71%	3.10%	24.50	2.35	9.59%	13.20%
BSX Boston Scientific Corp.	$52.01	-49.87%	0.00%	18.98	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$93.97	-25.21%	0.00%	20.36	5.96	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$562.20	-11.86%	0.00%	38.32	27.08	70.67%	25.03%
RMD ResMed Inc.	$230.65	-18.34%	1.07%	21.40	4.95	23.13%	26.94%
COHR Coherent Inc.	$287.47	217.68%	0.00%	79.32	5.68	7.16%	11.31%
PHG Koninklijke Philips NV	$27.62	4.58%	3.70%	20.19	1.98	9.80%	6.30%
SYK Stryker Corp.	$339.98	-9.77%	1.02%	34.97	5.44	15.55%	14.43%
INMD InMode Ltd.	$15.04	5.14%	0.00%	11.54	1.42	12.32%	20.69%
DXCM DexCom Inc.	$89.88	11.21%	0.00%	34.58	13.19	38.14%	20.12%
EW Edwards Lifesciences Corp.	$92.28	17.85%	0.00%	52.70	4.94	9.37%	15.43%
BDX Becton Dickinson and Company	$187.60	-0.85%	2.30%	53.25	2.05	3.85%	4.05%
IMRA Imara Inc.	$0.00	-100.00%	92.02%	65.05	1.13	1.74%	0.00%
BDXB Becton Dickinson and Company	$0.00	-100.00%	0.00%	8.75	0.54	6.12%	8.36%
ALGN Align Technology Inc.	$163.04	13.40%	0.00%	28.99	2.83	9.77%	9.99%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
IRMD iRadimed Corporation	$87.40	26.40%	1.45%	48.10	10.90	22.66%	26.71%
SNN Smith & Nephew PLC	$29.30	-16.53%	2.61%	11.16	2.43	21.74%	9.20%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

SIBN Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT SI-BONE

SI-BONE Inc.

Average Investor10 user rating

4.0 (1 people)

United States

18 years

Founded: 2008

2018

Time since IPO - 8 years

295

Employees

SI-BONE Inc. (United States) is listed on the Nasdaq and has a market capitalization of $834.24 million, with shareholders equity totaling $182.35 million.

The company employs approximately 295 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, SI-BONE Inc. reported $213.61 million in revenue, generating net income of $-14.63 million.

Key financial metrics include a P/E ratio of -57.02, a price-to-book (P/B) ratio of 4.57, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SIBN.

Market cap

$834.24 million

Net worth

$182.35 million

$182,350,000.00

Assets

$248.76 million

$248,760,000.00

Total Shares Outstanding

44.00 million

44,000,000

Average Daily Trading Volume

$540.94 Thousand

$540,939.06

Sector

Health

Industry

Medical Supplies and Equipment

SIBN

SIBN revenue and profits

Financial Results SIBN

DRAG THE FRAME TO SEE MORE DATA

SIBN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.65 36,41% (12M)

P/E

25.48

2.73%

ROE

6.12%

P/BV

1.56

CI - Cigna

$277.45 --6,37% (12M)

P/E

10.82

2.19%

ROE

16.04%

P/BV

1.74

CNC - Centene

$64.69 120,03% (12M)

P/E

-6.48

0.00%

ROE

-22.51%

P/BV

1.46

HUM - Humana

$378.02 32,24% (12M)

P/E

36.20

0.92%

ROE

6.63%

P/BV

2.40

SNY - Sanofi

$45.83 --5,73% (12M)

P/E

7.10

4.04%

ROE

18.43%

P/BV

1.31

LLY - Eli Lilly

$1,280.34 81,92% (12M)

P/E

39.62

0.54%

ROE

78.84%

P/BV

31.24

HCA - HCA Healthcare

$407.05 --0,11% (12M)

P/E

13.12

0.74%

ROE

-213.15%

P/BV

-27.97

NVS - Novartis

$160.31 28,43% (12M)

P/E

22.57

2.05%

ROE

30.41%

P/BV

6.87